Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
    • CFP AI policy
    • Politique du MFC en matière d'IA
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://cfpc.my.site.com/s/login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://cfpc.my.site.com/s/login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
    • CFP AI policy
    • Politique du MFC en matière d'IA
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
Review ArticleClinical Review

2025 update of the Greig Health Record

Part 2—what’s controversial?

Anita Greig, Fereshte Lalani, Cara Dosman, Akshay Verma, Jordana Sheps and Naima Javaid
Canadian Family Physician February 2026; 72 (2) 98-103; DOI: https://doi.org/10.46747/cfp.720298
Anita Greig
Family physician and Assistant Professor in the Department of Family and Community Medicine at the University of Toronto in Ontario.
MD FCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.greig{at}utoronto.ca
Fereshte Lalani
Family physician and Lecturer in the Department of Family and Community Medicine at the University of Toronto.
MD CCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cara Dosman
Developmental pediatrician and Associate Professor in the Division of Developmental Pediatrics at the University of Alberta in Edmonton.
MD FRCPC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akshay Verma
Family physician and Lecturer in the Department of Family and Community Medicine at the University of Toronto.
BMBS(UK) CCFP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordana Sheps
Family physician and Lecturer in the Department of Family and Community Medicine at the University of Toronto.
MD FCFP MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naima Javaid
Psychiatrist and Child and Youth Mental Health Lecturer in the Department of Psychiatry at the University of Toronto.
MD DABPN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Abstract

Objective To review a selection of new resources and updated recommendations from the third update of the Greig Health Record (GHR).

Sources of information Pediatric preventive care literature was reviewed using PubMed and Google Scholar databases. Systematic reviews of subtopics were evaluated where available. Guidance and supporting evidence were reviewed from the Canadian Paediatric Society, the American Academy of Pediatrics, the Canadian Task Force on Preventive Health Care, the United States Preventive Services Task Force, the National Advisory Committee on Immunization, and the Centers for Disease Control and Prevention.

Main message Recommendations for best practice are based on available evidence and guidance from various agencies; yet conflicting recommendations are often given. The GHR identifies 6 of these conflicts in pediatric preventive care recommendations, including depression screening; cannabis use counselling and screening; dietary recommendations for beverage selection and consumption of plant-based proteins; testicular self-examination; and meningococcal vaccination timing.

Conclusion Clinicians are advised to consider options for practice as they apply to their own patients and to be aware of changing guidance as new evidence emerges.

The Greig Health Record (GHR) is an evidence-based care guide used in preventive care visits for children and adolescents aged 6 to 17 years. It reviews and summarizes existing guidelines and presents the information in an easy-to-use format for clinicians. The GHR tool and its associated resources are available from https://greighealthrecord.ca.

Often guidelines on topics related to pediatric preventive care produce similar recommendations. However, conflicting recommendations from various agencies can occur due to differences in the methodology of literature evaluation, agendas and preferences of reviewers, targeted users, and proposed populations and settings for application.1 The GHR identifies 6 of these conflicts in pediatric preventive care recommendations, which include depression screening; cannabis use counselling and screening; dietary recommendations for beverage selection and consumption of plant-based proteins; testicular self-examination; and meningococcal vaccination timing. The GHR presents recommendations but leaves it to clinicians to consider options for practice and be aware of changing guidance as new evidence emerges.

Sources of information

Searches for pediatric preventive care literature for the period of 2016 to 2025 were performed using PubMed and Google Scholar databases. Systematic reviews of subtopics were evaluated where available. Additionally, guidance and supporting evidence were reviewed from major Canadian and American agencies, including the Canadian Paediatric Society (CPS), the American Academy of Pediatrics, the Canadian Task Force on Preventive Health Care (CTFPHC), the United States Preventive Services Task Force (USPSTF), the National Advisory Committee on Immunization (NACI), and the Centers for Disease Control and Prevention.

Main message

Should children and adolescents who are asymptomatic be screened for depression? Depression is a common symptom in adolescents and up to 1% to 2% of children aged 7 to 11 years suffer from depression.2 In 2023, 26% of Canadian adolescents rated their mental health as fair to poor.3

Most organizations that produce health guidelines recommend asking about mental health.4-7 In terms of population screening, the CPS recommends asking about emerging mental health problems at well-child visits and addressing social determinants of health, but no specific tools have been recommended. Systematic reviews have found insufficient evidence to make recommendations considering there have been no randomized clinical trials evaluating whether depression screening improves outcomes and no trials have addressed potential harms of screening.8,9 In 1994 the CTFPHC recommended against population screening. An updated recommendation is expected to be released in the near future.10

In contrast, the USPSTF recommends screening for major depressive disorder in adolescents (grade B recommendation) provided that there are resources for diagnosis and management.9 However, nonrandomized trials were included in their evaluation.9 The USPSTF has found insufficient evidence to recommend screening preadolescent children for depression or for suicide risk.11

The GHR recommends asking about mental health but does not recommend routine preventive screening with specific tools.12 An up-to-date recommendation will be made once the CTFPHC report is released. It should be emphasized that in children and youth who present with symptoms or behaviour suggesting depression or other mental health disorders that further investigation is recommended with validated screening tools. An anxiety and depression questionnaire is included for easy reference (Table 1).11,13-16

View this table:
  • View inline
  • View popup
Table 1.

Patient Health Questionnaire-4

Should the focus be on screening or counselling for reducing cannabis risk in youth? Cannabis use is common in Canadian youth and has been increasing. In the 2019 Canadian Cannabis Survey, 44% of teens aged 15 to 19 reported using cannabis in the preceding 12 months, compared with 36% in 2018.17 For comparison, a 2015 survey of Ontario students in grades 7 to 12 reported 21.5% used cannabis in the previous year.18

While avoiding cannabis altogether is recommended, in practice, youth are not always willing to abstain. Counselling to prevent initiation, encouraging reduction or quitting, and promoting other harm-reduction strategies may be helpful.

The CPS guidance differs from Canada’s Lower-Risk Cannabis Use Guidelines (LRCUG), with the former focusing on screening for use, praising abstinence, and supporting quitting or decreasing use; and the latter on harm reduction. Both are included in the resource tables of the GHR to allow clinicians to choose the best approach for their patients.19-21 It is suggested that wider dissemination of the LRCUG may help to increase the impact of harm-reduction stategies.22 It is important to note that inadvertent ingestion of cannabis, especially in the form of edibles, is also a concern, especially for younger children. Safe storage is recommended.23,24

The GHR also includes substance use in the checklist pages for children aged 6 to 9 as a prompt for anticipatory guidance. Whether there is a positive impact for early abstinence counselling will require further study (Boxes 1 and 2).19,25

Box 1.

Cannabis risk reduction

  • Avoid risks by choosing not to use

  • Delay starting cannabis use for as long as possible; there are more harms for teens, especially those younger than 16 years

  • Choose products with lower tetrahydrocannabinol content, or higher ratio of cannabidiol compared to tetrahydrocannabinol

  • Do not use synthetic cannabis products

  • Non-smoking options are less dangerous

  • If smoking, avoid inhaling deeply or holding your breath

  • Limit use, and try for infrequent, occasional use, or at most once per week

  • Do not drive when using, avoid driving for at least 6 hours, avoid combining with alcohol

  • Avoid if you or your family have a history of psychosis or substance use issues

  • Do not use if pregnant

  • Avoid inadvertent ingestion of edibles. Label clearly and place in locked storage

Data from the Canadian Research Initiative in Substance Matters and Centre for Addiction and Mental Health.25

Box 2.

Cannabis counselling guidelines

  • Provide a safe and confidential environment to screen for cannabis use

  • Ask about use of cannabis

  • Praise non-users for choosing to abstain from using cannabis

  • Consider cannabis as a contributing factor when youth complain of fatigue, low mood, and sleep issues

  • Provide support to decrease or stop use in cases of problematic use

  • Counsel about the impact on the developing brain (up to age 25 years)

  • Counsel about cannabis effects on mood and the potential for causing resurgence of depression or anxiety in those who have already experienced mood issues

Data from Bélanger and Grant.19

Should water be the beverage of choice? Are plant-based protein foods preferred? The nutritional recommendations chart in the supplemental pages of the GHR has been updated to reflect changes in Canada’s Food Guide. Recommendations include consuming plant-based protein foods and making water the beverage of choice.26 Water is specifically recommended but unsweetened low-fat cow’s milk and unsweetened soy and almond beverages are optional alternatives.27 Plant-based proteins are recommended to be consumed daily; the rationale is that these foods offer more fibre and less saturated fat than other protein foods.28 While the Canadian Guidelines are similar to updated guidelines from the United States and the United Kingdom, only the Canadian guidelines specifically state that water is the beverage of choice and that plant-based proteins should be chosen more often.29,30 The US guideline update recommends water to satisfy thirst and lower-fat dairy for calcium and other nutrients.29,31 The UK guidelines state the best drinks for children are water and milk but milk can be served as a main drink.32 The Canadian Guidelines do not address adequate calcium intake for bone health. The Canadian guidelines are summarized on the checklist pages of the GHR and Health Canada’s recommendations for calcium and vitamin D intake are in the resource pages to ensure clarity (Box 3 and Table 2).26,33-35

Box 3.

Nutritional recommendations

  • Eat vegetables, fruit, whole grains, and protein foods

  • Protein: Among protein foods consume plant-based more often. Protein foods include legumes, nuts, seeds, tofu, fortified soy beverage, fish, shellfish, eggs, poultry, lean red meat including wild game, lower-fat milk, lower-fat yogurts, lower-fat kefir, and cheeses lower in fat and sodium

  • Choose foods with mostly unsaturated fats rather than mostly saturated fats

  • Water should be the beverage of choice

  • Eating together (eg, family meals) can foster healthy eating habits

  • Energy needs are individual and should be adjusted to maintain a healthy weight

  • Processed or prepared items with excessive sodium, free sugars (such as sugary drinks and confectioneries), or saturated fat should not be consumed regularly. Unsweetened nutritious foods and beverages should be promoted instead of sugar substitutes

  • Cooking and preparing food at home can help support healthy eating. Food labels can help in making informed food choices

  • See https://www.canada.ca/en/health-canada/services/food-nutrition/healthy-eating/dietary-reference-intakes/tables/reference-values-elements.html

Data from Health Canada.26,35

View this table:
  • View inline
  • View popup
Table 2.

Nutrition recommended daily intake: No adjustment for latitude, pregnancy, or lactation.

Should adolescent males receive testicular self-examination counselling? Testicular cancer is the most common cancer in males aged 15 to 35 years.36,37 In 2004, and reaffirmed in 2011, the USPSTF recommended against counselling for testicular self-examination or routine clinical examination in individuals at average risk, in light of the low incidence of testicular cancer and favourable outcomes in the absence of screening.37 Time spent counselling for self-examination might be better spent on other topics. By contrast, the Canadian Cancer Society and the American Cancer Society recommend regular health visits and self-examination. Concern has been raised about a missed opportunity for early diagnosis and better outcomes, both medical and psychological.38,39 A description for self-examination is available.40 Provision of education in-person works better than written materials only.41

Despite these conflicting recommendations, patients should be advised to be aware of changes in their testicles and seek medical advice for any changes. Tables in the GHR are included to assist with counselling those who ask for more information (Box 4).40

Box 4.

Testicular self-examination

  • Who: Adolescent males or persons with testicles

  • Why: Most common cancer in adolescent males

  • Self-examination: Check for any changes such as a lump or tenderness (https://cancer.ca/en/cancer-information/cancer-types/testicular/finding-cancer-early and https://testicularcancersociety.org/pages/self-exam-how-to?)

  • Other symptoms: Feeling of heaviness in scrotum or lower abdomen; pain, possibly mild, in the testicle or scrotum

  • Next steps: See your doctor if you notice a change

Data from the Canadian Cancer Society.40

When should meningococcal vaccines be given? Creating a uniform recommendation for meningococcal vaccination for Canada is challenging as the epidemiology of invasive meningococcal disease (IMD) continues to change substantially and vary by age group and province or territory. Most IMD is caused by serotypes A, C, Y, and W135 combined but meningococcal B (MenB) strains account for the largest proportion of cases by single strain.42-44

Incidence of IMD in 11- and 12-year-olds is low. Recommendations for children younger than 12 years old are under review. Some studies indicate that carriage of meningococcus peaks around 19 years.45,46 Vaccine protection is of short duration; experts in the United States are considering whether later vaccination, such as in 16- and 17-year-olds, may be more efficacious.47 These considerations must be evaluated in the Canadian context.

Regarding MenB, there are currently 2 preparations of serogroup B meningococcal vaccine authorized for use in Canada. Neither has an effect on carriage, and as a result neither is effective in providing herd immunity. The NACI recommends MenB vaccination for persons at higher risk and advises MenB vaccines be considered on an individual basis.42,43 Following local public health guidelines is recommended. Ongoing evaluation of local serotypes and changing epidemiology will be necessary for future vaccination recommendations.48 A reminder to discuss immunization for MenB has been added to the GHR, although no specific recommendation for vaccination has been made at this time.

Conclusion

Conflicting recommendations may be the result of differing agendas for various agencies that produce guidelines. As evidence is evolving, lack of uniformity among guidelines may be the result of lag time in implementing new recommendations. Primary care providers are advised to stay abreast of new evidence. The GHR will be updated regularly and new recommendations will be explored.

Notes

Editor’s key points

  • ▸ The Greig Health Record (GHR) is an evidence-based care guide used in preventive care visits for children and adolescents aged 6 to 17 years old.

  • ▸ Conflicting guidelines and recommendations from various agencies can occur due to differences in the methodology of literature evaluation, agendas and preferences of reviewers, targeted users, and proposed populations and settings for application. The GHR covers 6 conflicts in pediatric preventive care recommendations: depression screening; cannabis use counselling and screening; dietary recommendations for beverage selection and consumption of plant-based proteins; testicular self-examination; and meningococcal vaccination timing.

  • ▸ The GHR presents differing recommendations but leaves it to clinicians to consider options for practice and be aware of changing guidance as new evidence emerges.

Points de repère du rédacteur

  • ▸ Le Relevé médical Greig (RMG) est un guide sur les soins de santé fondé sur des données probantes à utiliser lors des rendez-vous en santé préventive avec des enfants et des adolescents de 6 à 17 ans.

  • ▸ Les lignes directrices et les recommandations provenant de diverses organisations peuvent être conflictuelles en raison de différences dans la méthodologie d’évaluation de la littérature scientifique, les mandats et les préférences des réviseurs, les utilisateurs ciblés et les populations et milieux proposés pour leur mise en application. Le RMG porte sur 6 divergences dans les recommandations sur les soins préventifs pédiatriques : le dépistage de la dépression; le counseling et le dépistage liés à la consommation de cannabis; les recommandations alimentaires entourant le choix des boissons et la consommation des protéines à base de plantes; l’autoexamen des testicules; et le calendrier de vaccination contre les méningocoques.

  • ▸ Le RMG présente des recommandations divergentes, mais laisse aux cliniciens le choix d’envisager les options pour leur pratique et les incite à se tenir au fait des orientations changeantes au fur et à mesure de l’émergence de nouvelles données probantes.

Footnotes

  • Acknowledgment

    We thank Éliane Sauvé Greig for her work on the French language translations.

  • Contributors

    All authors contributed to conducting the literature review and to preparing the manuscript for submission.

  • Competing interests

    None declared

  • This article has been peer reviewed.

  • Copyright © 2026 the College of Family Physicians of Canada

References

  1. 1.↵
    1. Brouwers MC,
    2. Kho ME,
    3. Browman GP,
    4. Burgers JS, et al.
    AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010 Dec 14;182(18):E839-42. doi: 10.1503/cmaj.090449. Epub 2010 Jul 5.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Siu AL; U.S. Preventive Services Task Force
    . Screening for Depression in Children and Adolescents: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016 Mar 1;164(5):360-6. doi: 10.7326/M15-2957. Epub 2016 Feb 9.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Statistics Canada
    . 2023 Canadian Health Survey on Children and Youth—Changes in the mental health of respondents from the 2019 survey [Internet]. Government of Canada; 2024 Sep 10 [cited 2025 Nov 24]. Available from: https://www150.statcan.gc.ca/n1/daily-quotidien/240910/dq240910a-eng.htm.
  4. 4.↵
    1. Arruda W,
    2. Bélanger SA,
    3. Cohen JS,
    4. Hrycko S, et al.
    Promoting optimal mental health outcomes for children and youth. Paediatr Child Health. 2023 Oct 25;28(7):417-36. doi: 10.1093/pch/pxad032.
    OpenUrlCrossRef
  5. 5.
    1. U.S. Preventive Services Task Force
    . Depression and Suicide Risk in Children and Adolescents: Screening [Internet]. U.S. Preventive Services Task Force; 2022 Oct 11 [cited 2025 Nov 24]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-children-adolescents.
  6. 6.
    1. Wissow LS,
    2. Brown J,
    3. Fothergill KE,
    4. Gadomski A, et al.
    Universal mental health screening in pediatric primary care: a systematic review. J Am Acad Child Adolesc Psychiatry. 2013 Nov;52(11):1134-47.e23. doi: 10.1016/j.jaac.2013.08.013. Epub 2013 Aug 30. Erratum in: J Am Acad Child Adolesc Psychiatry. 2014 Mar;53(3):382.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. American Academy of Pediatrics
    . Preventive Care/Periodicity Schedule [Internet]. American Academy of Pediatrics; 2023 [cited 2025 Nov 24]. Available from: https://www.aap.org/periodicityschedule.
  8. 8.↵
    1. Beck A,
    2. Dryburgh N,
    3. Bennett A,
    4. Shaver N, et al.
    Screening for depression in children and adolescents in primary care or non-mental health settings: a systematic review update. Syst Rev. 2024 Jan 31;13(1):48. doi: 10.1186/s13643-023-02447-3.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Roseman M,
    2. Saadat N,
    3. Riehm KE,
    4. Kloda LA, et al.
    Depression Screening and Health Outcomes in Children and Adolescents: A Systematic Review. Can J Psychiatry. 2017 Dec;62(12):813-7. doi: 10.1177/0706743717727243. Epub 2017 Aug 29.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Canadian Task Force on Preventive Health Care
    . Depression in children and adolescents [Internet]. Canadian Task Force on Preventive Health Care; 2025 [cited 2025 Nov 24]. Available from: https://canadiantaskforce.ca/guidelines/upcoming-guidelines/depression-in-children-and-adolescents/.
  11. 11.↵
    1. Centre for Effective Practice
    . Youth Mental Health [Internet]. Centre for Effective Practice; 2017 Jun [cited 2025 Nov 24]. Available from: https://cep.health/clinical-products/youth-mental-health/.
  12. 12.↵
    1. Richardson LP,
    2. Rockhill C,
    3. Russo JE,
    4. Grossman DC, et al.
    Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents. Pediatrics. 2010 May;125(5):e1097-103. doi: 10.1542/peds.2009-2712. Epub 2010 Apr 5.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Kroenke K,
    2. Spitzer RL,
    3. Williams JB,
    4. Löwe B.
    An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009 Nov-Dec;50(6):613-21. doi: 10.1176/appi.psy.50.6.613.
    OpenUrlCrossRefPubMed
  14. 14.
    1. Richardson LP,
    2. Rockhill C,
    3. Russo JE,
    4. Grossman DC, et al.
    Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents. Pediatrics. 2010 May;125(5):e1097-103. doi: 10.1542/peds.2009-2712. Epub 2010 Apr 5.
    OpenUrlCrossRefPubMed
  15. 15.
    1. Pfizer
    . Welcome to the Patient Health Questionnaire (PHQ) Screeners [Internet]. Pfizer; 2010 [cited 2025 Nov 25]. Available from: https://www.phqscreeners.com/select-screener.
  16. 16.↵
    1. Child and Adolescent Bipolar Spectrum Services
    . Clinical tools [Internet]. University of Pittsburgh; [cited 2025 Nov 25]. Available from: https://www.pediatricbipolar.pitt.edu/clinical-services/clinical-tools.
  17. 17.↵
    1. Health Canada
    . Canadian Cannabis Survey 2019—Summary [Internet]. Government of Canada; 2019 Dec 13 [cited 2025 Nov 24]. Available from: https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2019-summary.html.
  18. 18.↵
    1. Sampasa-Kanyinga H,
    2. Hamilton HA,
    3. LeBlanc AG,
    4. Chaput JP.
    Cannabis use among middle and high school students in Ontario: a school-based cross-sectional study. CMAJ Open. 2018 Jan 23;6(1):E50-6. doi: 10.9778/cmajo.20170159.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Bélanger RE,
    2. Grant CN.
    Counselling adolescents and parents about cannabis: A primer for health professionals. Paediatr Child Health. 2020 Jun 15;25(Suppl 1):S34-40. doi: 10.1093/pch/pxaa048.
    OpenUrlCrossRef
  20. 20.
    1. Fischer B,
    2. Russell C,
    3. Sabioni P,
    4. van den Brink W, et al.
    Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. Am J Public Health. 2017 Aug;107(8):e1-12. doi: 10.2105/AJPH.2017.303818. Epub 2017 Jun 23. Erratum in: Am J Public Health. 2018 May;108(5):e2. doi: 10.2105/AJPH.2017.303818e.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Carpino M,
    2. Langille D,
    3. Ilie G,
    4. Asbridge M.
    Cannabis-related driving and passenger behaviours among high school students: a cross-sectional study using survey data. CMAJ Open. 2020 Nov 24;8(4):E754-61. doi: 10.9778/cmajo.20200081.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Lee CR,
    2. Lee A,
    3. Goodman S,
    4. Hammond D, et al.
    The Lower-Risk Cannabis Use Guidelines’ (LRCUG) recommendations: How are Canadian cannabis users complying? Prev Med Rep. 2020 Aug 26;20:101187. doi: 10.1016/j.pmedr.2020.101187.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Grant C,
    2. Plebon-Huff S,
    3. Perwaiz S,
    4. Abramovici H, et al.
    Serious and life-threatening events associated with non-medical cannabis use in Canadian children and youth. Paediatr Child Health. 2023 Jun 26;29(1):3-4. doi: 10.1093/pch/pxad036.
    OpenUrlCrossRef
  24. 24.↵
    1. Health Canada
    . Public advisory. Accidental ingestion of edible cannabis products causing serious harm to children [Internet]. Government of Canada; 2020 Aug 13 [cited 2025 Nov 24]. Available from: https://recalls-rappels.canada.ca/en/alert-recall/accidental-ingestion-edible-cannabis-products-causing-serious-harm-children.
  25. 25.↵
    1. Canadian Research Initiative in Substance Matters, Centre for Addiction and Mental Health
    . Canada’s Lower-Risk Cannabis Use Guidelines (LRCUG) [Internet]. Canadian Research Initiative in Substance Matters, Centre for Addiction and Mental Health; [cited 2025 Nov 26]. Available from: https://www.camh.ca/-/media/files/lrcug_professional-pdf.
  26. 26.↵
    1. Health Canada
    . Canada’s food guide. Resources for health professionals and policy makers [Internet]. Government of Canada; 2024 [cited 2025 Nov 24]. Available from: https://food-guide.canada.ca/en/guidelines.
  27. 27.↵
    1. Health Canada
    . Canada’s food guide. Make water your drink of choice [Internet]. Government of Canada; 2021 Jan 26 [cited 2025 Nov 24]. Available from: https://food-guide.canada.ca/en/healthy-eating-recommendations/make-water-your-drink-of-choice/#section-4.
  28. 28.↵
    1. Health Canada
    . Canada’s food guide. Eat protein foods [Internet]. Government of Canada; 2022 May 3 [cited 2025 Nov 24]. Available from: https://food-guide.canada.ca/en/healthy-eating-recommendations/make-it-a-habit-to-eat-vegetables-fruit-whole-grains-and-protein-foods/eat-protein-foods/.
  29. 29.↵
    1. U.S. Department of Agriculture, U.S. Department of Health and Human Services
    . Dietary Guidelines for Americans [Internet]. U.S. Department of Agriculture, U.S. Department of Health and Human Services; [cited 2025 Nov 24]. Available from: https://www.dietaryguidelines.gov/.
  30. 30.↵
    1. National Health Service
    . The Eatwell Guide [Internet]. National Health Service; 2022 [cited 2025 Nov 24]. Available from: https://www.nhs.uk/live-well/eat-well/food-guidelines-and-food-labels/the-eatwell-guide/.
  31. 31.↵
    1. Office of Disease Prevention and Health Promotion
    . Make Healthy Drink Choices [Internet]. U.S. Department of Agriculture, U.S. Department of Health and Human Services; 2025 [cited 2025 Nov 24]. Available from: https://www.dietaryguidelines.gov/sites/default/files/2021-12/DGA_Beverages_FactSheet-508c.pdf.
  32. 32.↵
    1. National Health Service
    . Water, drinks and hydration [Internet]. National Health Service; 2023 May 17 [cited 2025 Nov 24]. Available from: https://www.nhs.uk/live-well/eat-well/food-guidelines-and-food-labels/water-drinks-nutrition/.
  33. 33.↵
    1. Health Canada
    . Vitamin D [Internet]. Government of Canada; 2022 May 2 [cited 2025 Nov 24]. Available from: https://www.canada.ca/en/health-canada/services/nutrients/vitamin-d.html.
  34. 34.
    1. Demay MB,
    2. Pittas AG,
    3. Bikle DD,
    4. Diab DL, et al.
    Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024 Jul 12;109(8):1907-47. doi: 10.1210/clinem/dgae290. Erratum in: J Clin Endocrinol Metab. 2025 Feb 18;110(3):e916. doi: 10.1210/clinem/dgae854. Erratum in: J Clin Endocrinol Metab. 2025 Jul 15;110(8):e2810. doi: 10.1210/clinem/dgaf310.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Health Canada
    . Dietary reference intakes tables: reference values for elements [Internet]. Government of Canada; 2023 Dec 18 [cited 2025 Nov 24]. Available from: https://www.canada.ca/en/health-canada/services/food-nutrition/healthy-eating/dietary-reference-intakes/tables/reference-values-elements.html.
  36. 36.↵
    1. Health Canada
    . Canadian Cancer Data Tool [Internet]. Government of Canada; 2021 Feb 25 [cited 2025 Nov 24]. Available from: https://health-infobase.canada.ca/ccdt/?0=0&1=0&2=0.
  37. 37.↵
    1. U.S. Preventive Services Task Force
    . Screening for testicular cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2011 Apr 5;154(7):483-6. doi: 10.7326/0003-4819-154-7-201104050-00006.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Fadich A,
    2. Giorgianni SJ,
    3. Rovito MJ,
    4. Pecchia GA, et al.
    USPSTF Testicular Examination Nomination-Self-Examinations and Examinations in a Clinical Setting. Am J Mens Health. 2018 Sep;12(5):1510-6. doi: 10.1177/1557988318768597. Epub 2018 May 2.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Wood L,
    2. Kollmannsberger C,
    3. Jewett M,
    4. Chung P, et al.
    Canadian consensus guidelines for the management of testicular germ cell cancer. Can Urol Assoc J. 2010 Apr;4(2):e19-38. doi: 10.5489/cuaj.815.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Canadian Cancer Society
    . Testicular Cancer [Internet]. Canadian Cancer Society; 2025 [cited 2025 Nov 24]. Available from: https://cancer.ca/en/cancer-information/cancer-types/testicular.
  41. 41.↵
    1. Thornton CP.
    Best Practice in Teaching Male Adolescents and Young Men to Perform Testicular Self-Examinations: A Review. J Pediatr Health Care. 2016 Nov-Dec;30(6):518-27. doi: 10.1016/j.pedhc.2015.11.009. Epub 2016 Jan 9.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Public Health Agency of Canada
    . Summary of updates of National Advisory Committee on Immunization advice on invasive meningococcal disease in the Canadian Communicable Disease Report: September 25, 2023 [Internet]. Government of Canada; 2023 Sep 25 [cited 2025 Nov 24]. Available from: https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-summary-updates-invasive-meningococcal-disease-ccdr.html.
  43. 43.↵
    1. Pham-Huy A,
    2. Zafack J,
    3. Primeau C,
    4. Baclic O, et al.
    A National Advisory Committee on Immunization (NACI) update on invasive meningococcal disease (IMD) epidemiology and program-relevant considerations for preventing IMD in individuals at high risk of exposure. Can Commun Dis Rep. 2023 Sep 1;49(9):358-67. doi: 10.14745/ccdr.v49i09a01.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Public Health Agency of Canada
    . Meningococcal vaccines. Canadian Immunization Guide [Internet]. Government of Canada; 2024 May 1 [cited 2025 Nov 24]. Available from: https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-13-meningococcal-vaccine.html.
  45. 45.↵
    1. Vetter V,
    2. Baxter R,
    3. Denizer G,
    4. Sáfadi MA, et al.
    Routinely vaccinating adolescents against meningococcus: targeting transmission & disease. Expert Rev Vaccines. 2016 May;15(5):641-58. doi: 10.1586/14760584.2016.1130628. Epub 2016 Mar 4.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Christensen H,
    2. May M,
    3. Bowen L,
    4. Hickman M, et al.
    Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010 Dec;10(12):853-61. doi: 10.1016/S1473-3099(10)70251-6. Epub 2010 Nov 11. Erratum in: Lancet Infect Dis. 2011 Aug;11(8):584.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Gaviria-Agudelo C,
    2. Yonts AB,
    3. Kimberlin DW,
    4. Campbell JD, et al.
    February 2024 ACIP Meeting Update: Meningococcal, RSV, COVID-19, and Other Vaccines. Pediatrics. 2024 Jun 1;153(6):e2024066653. doi: 10.1542/peds.2024-066653.
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. Findlow J,
    2. Nuttens C,
    3. Kriz P.
    Introduction of a second MenB vaccine into Europe - needs and opportunities for public health. Expert Rev Vaccines. 2019 Mar;18(3):225-39. doi: 10.1080/14760584.2019.1578217. Epub 2019 Mar 1.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

Canadian Family Physician: 72 (2)
Canadian Family Physician
Vol. 72, Issue 2
1 Feb 2026
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
2025 update of the Greig Health Record
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
2025 update of the Greig Health Record
Anita Greig, Fereshte Lalani, Cara Dosman, Akshay Verma, Jordana Sheps, Naima Javaid
Canadian Family Physician Feb 2026, 72 (2) 98-103; DOI: 10.46747/cfp.720298

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
2025 update of the Greig Health Record
Anita Greig, Fereshte Lalani, Cara Dosman, Akshay Verma, Jordana Sheps, Naima Javaid
Canadian Family Physician Feb 2026, 72 (2) 98-103; DOI: 10.46747/cfp.720298
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Sources of information
    • Main message
    • Conclusion
    • Notes
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Approach to mallet finger injury
  • Approach to obstructive sleep apnea
Show more Clinical Review

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2026 by The College of Family Physicians of Canada

Powered by HighWire